Key Developments: Stryker Corp (SYK)
67.26USD
24 May 2013
$0.02 (+0.03%)
$67.24
$67.00
$67.30
$66.58
475,919
1,591,995
$70.00
$49.43
Latest Key Developments (Source: Significant Developments)
Stryker Corp Declares $0.265 Per Share Quarterly Dividend
Stryker Corp announced that its Board of Directors has declared a quarterly dividend of $0.265 per share payable on July 31, 2013, to shareholders of record at the close of business on June 28, 2013, representing an increase of 25% versus the prior year. Full Article
Stryker Corp Issues FY 2013 Guidance In Line With Analysts' Estimates-Conference Call
Stryker Corp announced that for fiscal 2013, it expects sales growth, excluding foreign exchange and acquisitions, of 3% to 5.5%, with adjusted diluted net earnings per share (EPS) of $4.25 to $4.40. The Company reported revenue of $8.657 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $8.96 billion and EPS of $4.29 for fiscal 2013. Full Article
Stryker Corp Declares $0.265 Per Share Quarterly Dividend
Stryker Corp announced that its Board of Directors has declared a quarterly dividend of $0.265 per share payable on April 30, 2013, to shareholders of record at the close of business on March 28, 2013. Full Article
Stryker Corp Issues FY 2013 Revenue Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EPS Gudiance-Conference Call
Stryker Corp announced that for fiscal 2013, it expects sales growth, excluding foreign exchange and acquisitions, of 3% to 5.5%, with adjusted diluted net earnings per share (EPS) of $4.25 to $4.40, up 4% to 8%, which includes the roughly $100 million pretax impact from the medical device excise tax. The Company reported revenue of $8.657 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $8.96 billion and EPS of $4.31 for fiscal 2013. Full Article
Stryker Corp To Buy Hong Kong's Trauson Holdings Co Ltd For $764 Million-Reuters
Reuters reported that Stryker Corp will buy Hong Kong-based Trauson Holdings Co Ltd for $764 million in an all cash deal, to expand in one of the fastest-growing markets for orthopaedic products in China. Stryker will pay HKD7.50 ($0.97) for every share of Trauson. Trauson's controlling shareholder, Luna Group, has agreed to tender 61.7% of Trauson shares. Full Article
Stryker Corp Reaffirms FY 2012 EPS Guidance; Reaffirms FY 2013 Guidance-Conference Call
Stryker Corp announced that for fiscal 2012, it expects adjusted diluted net earnings per share to be in the range of $4.05 to $4.07, an increase of 8.9% to 9.4% over adjusted diluted net earnings per share of $3.72 in 2011. For fiscal 2013, it expects sales to growth in a range of 3.0% to 5.5%. If foreign currency exchange rates hold near current levels, the Company anticipates net sales will be negatively impacted by approximately 0% to 1% in both the first quarter and fiscal 2013 and as previously communicated, the Company projects 2013 adjusted diluted net earnings per share,including the estimated $100 million (pre-tax) annual impact from the medical device excise tax, to be in a range of $4.25 to $4.40. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $4.05 for fiscal 2012. Full Article
Stryker Corp Declares 25% Increase In Quarterly Dividend and Announces Increase In Share Repurchase Authorization To $1 Billion
Stryker Corp announced that Board of Directors has increased its dividend 25% by declaring a quarterly dividend of $0.265 per share payable on January 31, 2013, to shareholders of record at the close of business on December 31, 2012. Stryker also announced that its Board of Directors has authorized the Company to repurchase an additional $405 million of its common stock, which raises the total share repurchase authorization to $1 billion. The repurchases will occur at such times and prices as the management of the company determines and may be effected through transactions in the open market, in privately negotiated transactions or otherwise. Full Article
Stryker Corp Narrows FY 2012 Revenue Guidance; Raises FY 2012 EPS Guidance; Issues FY 2013 EPS Guidance Below Analysts' Estimates-Conference Call
Stryker Corp narrowed fiscal 2012 sales range from 2%-5% to 2.5%-4%, underlying revenue growth excluding the impact of foreign currency and acquisitions. Fiscal 2012 adjusted earnings per share (EPS) is to be in the range of $4.04 to $4.07, up approximately 9% compared to prior target of double-digit year over year earnings growth. For fiscal 2013, it expects adjusted EPS in a range of $4.25 to $4.40, up approximately 5% to 8%, which includes an estimated $100 million impact from the medical device excise tax. Excluding the tax, the Company is targeting 9% to 12% EPS growth. The Company reported revenue of $8.307 billion in fiscal 2011. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $8.62 billion for fiscal 2012; EPS of $4.41 for fiscal 2013. Full Article
Stryker Corp Reaffirms FY 2012 Guidance; Comments On Long Term EPS Guidance-Conference Call
Stryker Corp announced that for fiscal 2012, it is targeting 3.5% to 6.5% sales growth excluding FX, 2% to 5% excluding FX and acquisitions. FX is currently estimated to be a headwind of 1% to 2%, and the net earnings targeting is not less than 10% growth. For long-term growth goal of 10% earnings per share, not less than 10% earnings per share. The Company reported revenue of $8.307 billion and EPS of $3.72 in fiscal 2011. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $8.63 billion and EPS of $4.09 for fiscal 2012. Full Article
Stryker Corp Declares $0.2125 Per Share Quarterly Dividend
Stryker Corp announced that its Board of Directors has declared a quarterly dividend of $0.2125 per share payable on October 31, 2012, to shareholders of record at the close of business on September 28, 2012, representing an increase of 18% versus the prior year. Full Article
UPDATE 1-Stryker names Dentsply executive as chief financial officer
April 8 - Medical products maker Stryker Corp on Monday named William Jellison as chief financial officer, replacing Dean Bergy, who was interim CFO.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
